Image Description (Milla Pharmaceuticals Company Logo)
Sodium Acetate Injection, Solution, Concentrate
Product Images NDC 71357-002
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sodium Acetate (NDC 71357-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Milla Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image Description (Sodium Acetate 40meq 20ml Carton Label)
Sodium Acetate injection, USP, concentrate, 40 mEq/20 mL (2 mEq/mL) in single-dose vials. Label indicates it must be diluted before intravenous use. Contains 164 mg/mL sodium acetate, anhydrous. Manufactured by Milla Pharmaceuticals Inc. Label provides storage instructions, aseptic technique caution, and barcode.*
Image Description (Sodium Acetate 40meq 20ml Vial Label)
Label of Sodium Acetate Injection, USP, 40 mEq/20 mL (2 mEq/mL), in a 20 mL single-dose vial. The label includes a caution that the product must be diluted and states for intravenous use only. It provides details on active ingredient strength (164 mg/mL), pH, sterility, storage, and manufacturer information for Milla Pharmaceuticals Inc.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
